1
Enquiry period
with 18.02.2025 14:38
to 24.02.2025 14:50
2 days left
2
Bidding period
with 24.02.2025 14:50
to 27.02.2025 15:00
3
Auction
28.02.2025 13:00
4
Evaluation

5
Contract

Status Enquiry period
Estimated value without VAT 158 566,99 MDL
Period of clarifications: 18 Feb 2025, 14:38 - 24 Feb 2025, 14:50
Submission of proposals: 24 Feb 2025, 14:50 - 27 Feb 2025, 15:00

Supplier technical support:

(+373) 79999801

Subscribe

“Achiziţionarea medicamentelor pentru realizarea Programului Naţional de prevenire și control HIV/SIDA și ITS pentru anul 2025 (repetat nr. 4)”

Information about customer
Fiscal code/IDNO
Address
MD-2005, MOLDOVA, mun.Chişinău, locality, mun. Chișinău MD-2005, bd. Grigore Vieru, 22/2
Web site
---
The contact person
Full name
Macari Doina
Contact phone
+37322222490
Purchase data
Date created
18 Feb 2025, 14:19
Date modified
18 Feb 2025, 14:38
Achizitii.md ID
21367087
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Request price offers (goods)
Award criteria
The lowest price
Funding sources
Documents of the procurement procedure
DUAE Model
Bidding Documents
DUAE Model
18.02.25 14:38
Documentatia standard Hiv.signed
Bidding Documents
Documentatia standard Hiv.signed
18.02.25 14:38
Propunerea financiară
Technical Specifications
Propunerea financiară
18.02.25 14:38
Cerere de participare_Model
Bidding Documents
Cerere de participare_Model
18.02.25 14:38
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
18.02.25 14:38
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
18.02.25 14:38
Anunt de participare Hiv.signed
Bidding Documents
Anunt de participare Hiv.signed
18.02.25 14:38
Propunerea tehnică
Technical Specifications
Propunerea tehnică
18.02.25 14:38
Model de contract
Bidding Documents
Model de contract
18.02.25 14:38
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
18.02.25 14:38
Question's name
Question
Only authorized platform users may ask questions during the clarification period.